What are cancer trials?
Key facts about cancer trials
Cancer clinical trials, also called cancer trials, help advance medical research that could benefit people living with cancer now and in the future. A clinical trial is a voluntary research study that is conducted to help answer important, specific questions about the safety and effectiveness of:
- Investigational treatments or therapies
- Different ways of using existing treatments
Find a cancer trial near you
How cancer trials work
Participating in a cancer clinical trial gives you the opportunity to access emerging research treatments while being cared for by doctors and nurses connected with the study.
In most cases, when you enroll in a clinical study, you will receive either a currently approved standard treatment or a new study treatment that is undergoing multiple phases of testing and review to see if it is safe and effective. It is worth nothing that placebos (medicines with no active ingredients) are rarely used in cancer trials, and typically only when there is no current treatment or when it is being compared to a current treatment.
Taking part in a clinical trial is your choice. If you decide to take part, you may leave at any time for any reason.
Different types of cancer trials
- Prevention trials
- Screening trials
- Diagnostic trials
- Supportive care/quality-of-life trials
Cancer trials phases
Phase 1—about 20 to 100 participants
In a Phase 1 clinical trial, the research treatment is tested on a small group of people to determine the best dose of the research treatment as well as discover the most common side effects.
Phase 2—up to a few hundred participants
Phase 3—about 300 to 3,000 participants, depending on how common the type of cancer is
The goal in this phase is to see how safe the research treatment is and how well it works compared to a standard approved treatment. The number of participants will depend on how common or rare the type of disease or condition being studied is.
In a Phase 3 cancer study, participants will be assigned to either a group that receives a standard treatment or a group that gets a research treatment. Participants are randomly assigned, which means they won’t know which group they will be placed in, but they have an equal chance to receive either treatment.
The outcomes of the two groups are compared to see which group benefitted more. If the group that received the research treatment benefits more than the one that received the existing approved treatment, the research data is typically used to file for FDA approval. This is done so that the research treatment can be approved for doctors to start prescribing the treatment.
Why Phase 3 Is So Important
Out of all the trial phases, Phase 3 cancer clinical trials usually include the largest number of participants. This allows the participants to be diverse and reflective of the people who are most commonly diagnosed with the type of cancer being treated in the trial. The results of a Phase 3 trial are pivotal as they provide comprehensive safety and efficacy information.
Phase 4—several thousand participants
If a cancer trial hasn't been brought up by your doctor, it doesn't mean that you’re not eligible. You should always ask your doctor to find out if there are ongoing trials that might benefit you.